This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Stocks in play: PharmaCielo Ltd.

Baystreet.ca - Baystreet - Fri Apr 17, 8:59AM CDT

Today announced that it intends to issue, subject to the approval of the TSX Venture Exchange, 11,145,999 common shares of PharmaCielo, at an effective price of $0.08 per Interest Share, in satisfaction of an aggregate of $891,681.85 in accrued semi annual interest payments due to holders of the Company's 11% secured debentures. PharmaCielo Ltd. shares V.PCLO are trading unchanged at $0.05.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).